These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 5078840)

  • 1. [Vascular filling by means of association of a balanced sodium solute and a modified fluid gelatin].
    Joder F; Laborit G
    Agressologie; 1972; 13(2):135-42. PubMed ID: 5078840
    [No Abstract]   [Full Text] [Related]  

  • 2. [A new balanced sodium solution in the treatment of hemorrhage].
    Nahas GG; Vourc'h G; Radiguet de la Bastaie P; Triner L; Debbas E; Habif DV
    Presse Med (1893); 1970 Jan; 78(1):19-22. PubMed ID: 5436755
    [No Abstract]   [Full Text] [Related]  

  • 3. [The place of balanced sodium solutions in the treatment of hemorrhage].
    Vourc'h G; Radiguet de la Bastaie P; Triner L; Debbas E; Habif DV; Nahas GG
    Anesth Analg (Paris); 1970; 27(5):737-57. PubMed ID: 5481448
    [No Abstract]   [Full Text] [Related]  

  • 4. Randomized evaluation of fluid resuscitation with crystalloid (saline) and colloid (polymer from degraded gelatin in saline) in pediatric septic shock.
    Upadhyay M; Singhi S; Murlidharan J; Kaur N; Majumdar S
    Indian Pediatr; 2005 Mar; 42(3):223-31. PubMed ID: 15817970
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical experience with 120,000 units of modified fluid gelatin.
    Lundsgaard-Hansen P; Tschirren B
    Dev Biol Stand; 1980; 48():251-6. PubMed ID: 7274558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Relationships between intravascular retention time, perfusion and metabolic dysregulation during infusion of colloidal and crystalloid solutions in hemorrhagic shock].
    Kilian J; Dölp R
    Bibl Haematol; 1971; 37():342-7. PubMed ID: 5138920
    [No Abstract]   [Full Text] [Related]  

  • 7. [Experimental study on modified fluid gelatin as a serum volume expander].
    Murakami S; Hamabe N; Kitani M; Ota Y; Tanigawa H
    Masui; 1969 Jun; 18(6):500-9. PubMed ID: 5816994
    [No Abstract]   [Full Text] [Related]  

  • 8. Evaluation of modern plasma expanders and blood substitutes.
    Rudowski WJ
    Br J Hosp Med; 1980; 23(4):389-99. PubMed ID: 6155961
    [No Abstract]   [Full Text] [Related]  

  • 9. [Chemical characterization of a plasma substitute preparation].
    Bonhard K
    Arzneimittelforschung; 1971 Nov; 21(11):1667-71. PubMed ID: 5172075
    [No Abstract]   [Full Text] [Related]  

  • 10. [Determination of molecular weight of plasma substitute, gelatinol solution, by the viscosimetric method].
    Shlimak VM; Znamenskaia TV; Lazareva IV; Dmitrenko LV; Kallistov OV
    Probl Gematol Pereliv Krovi; 1976 Apr; 21(4):56-8. PubMed ID: 1025553
    [No Abstract]   [Full Text] [Related]  

  • 11. Volume therapy with colloid solutions preserves intestinal microvascular perfusion in endotoxaemia.
    Schäper J; Ahmed R; Schäfer T; Elster A; Enigk F; Habazettl H; Mousa S; Schäfer M; Welte M
    Resuscitation; 2008 Jan; 76(1):120-8. PubMed ID: 17697734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Modezhel' erythrocyte preservative as an experimental and clinical blood substitute].
    Selivanov EA; Mel'nikova VN; Kochetygov NI; Pleshakov VT; Gerbut KA; Krivtsova IM; Lur'e GO
    Vestn Khir Im I I Grek; 1996; (1):71-4. PubMed ID: 8753967
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The current use in France of modified fluid gelatins as plasma expanders.
    Nahas GG; Vourch G; Tannieres ML
    Prog Clin Biol Res; 1978; 19():259-64. PubMed ID: 662883
    [No Abstract]   [Full Text] [Related]  

  • 14. Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery.
    Schroth M; Plank C; Meissner U; Eberle KP; Weyand M; Cesnjevar R; Dötsch J; Rascher W
    Pediatrics; 2006 Jul; 118(1):e76-84. PubMed ID: 16751617
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Comparative study of the effect of Adona on the plasma volume].
    Papatheodossiou N
    Helv Chir Acta; 1979 Feb; 45(6):803-11. PubMed ID: 155050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of a new perfluorocarbon emulsion on human plasma and whole-blood viscosity in the presence of albumin, hydroxyethyl starch, or modified fluid gelatin: an in vitro rheologic approach.
    Jouan-Hureaux V; Audonnet-Blaise S; Lacatusu D; Krafft MP; Dewachter P; Cauchois G; Stoltz JF; Longrois D; Menu P
    Transfusion; 2006 Nov; 46(11):1892-8. PubMed ID: 17076843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Modern therapy of shock].
    Borst HG
    Chirurg; 1967 Mar; 38(3):104-9. PubMed ID: 4871895
    [No Abstract]   [Full Text] [Related]  

  • 18. [Experimental study on modified fluid gelatin as a plasma substitute (2)].
    Tosaki Y; Shirai T; Taori M
    Masui; 1969 Oct; 18(10):932-41. PubMed ID: 5390132
    [No Abstract]   [Full Text] [Related]  

  • 19. Hemostatic changes after crystalloid or colloid fluid administration during major orthopedic surgery: the role of fibrinogen administration.
    Mittermayr M; Streif W; Haas T; Fries D; Velik-Salchner C; Klingler A; Oswald E; Bach C; Schnapka-Koepf M; Innerhofer P
    Anesth Analg; 2007 Oct; 105(4):905-17, table of contents. PubMed ID: 17898365
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Do plasma substitutes have additional properties beyond correcting volume deficits?: Shock 25:2103-116, 2006.
    Wiedermann CJ
    Shock; 2007 Mar; 27(3):339-42. PubMed ID: 17304118
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.